Related Experiment Videos
Surgical options for patients with advanced emphysema
1Department of Medicine, University of Washington Medical Center, Seattle, USA.
Clinics in Chest Medicine
|November 5, 1997
Summary
Lung Volume Reduction Surgery (LVRS) may improve symptoms and quality of life for emphysema patients. A large trial will compare LVRS to medical therapy to answer key questions about its effectiveness and safety.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Critical Care Medicine
Background:
- Emphysema treatment has historically lacked effective surgical options, with giant bullectomy being suitable for few patients.
- Existing data suggests Lung Volume Reduction Surgery (LVRS) can improve symptoms and physiological function in selected emphysema patients.
- LVRS presents a potentially rapid, effective, and cost-effective intervention for managing debilitating emphysema.
Purpose of the Study:
- To compare Lung Volume Reduction Surgery (LVRS) against maximal medical therapy for emphysema.
- To determine the duration of LVRS benefits and identify optimal surgical approaches.
- To establish patient characteristics predicting outcomes, the role of pulmonary rehabilitation, and LVRS's impact on lung function decline, cost, safety, quality of life, and mortality.
Main Methods:
- A prospective, randomized controlled trial is planned involving 18 academic medical centers.
- The trial is sponsored by the Health Care Financing Administration and the National Institutes of Health.
- This study aims to provide definitive answers to critical questions regarding LVRS efficacy and safety.
Main Results:
- Data from academic centers indicate LVRS may ameliorate symptoms and improve pulmonary physiology, function, and quality of life in appropriately selected emphysema patients.
- LVRS offers a potentially rapid, effective, and cost-effective intervention for this chronic disease.
- Further research is needed to confirm these preliminary findings and address outstanding questions.
Conclusions:
- LVRS shows promise as a therapeutic option for selected emphysema patients, potentially improving quality of life and physiological function.
- A large-scale, multi-center randomized controlled trial is essential to definitively answer critical questions regarding LVRS efficacy, safety, and long-term outcomes compared to medical management.
- The initiation of this trial by government agencies highlights the critical need for evidence-based evaluation of new surgical therapies for chronic lung diseases.